Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Strategic Asset Allocation Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Strategic Asset Allocation Index of 43.5% as of June 2023. Strategic assets (PP&E of CN¥6.08 Billion plus long-term investments of CN¥-) total CN¥6.08 Billion, measured against net assets of CN¥13.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shanghai Shyndec Pharmaceutical Co Ltd (600420) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shanghai Shyndec Pharmaceutical Co Ltd Strategic Asset Allocation Index (2001–2021)
This chart shows how Shanghai Shyndec Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2001 to 2021. As of June 2023, the index stands at 43.5%, representing strategic assets of CN¥6.08 Billion against net assets of CN¥13.98 Billion CNY. For live market cap and overall valuation, see how much is Shanghai Shyndec Pharmaceutical Co Ltd worth.
Annual Strategic Asset Allocation Index for Shanghai Shyndec Pharmaceutical Co Ltd (2001–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Shyndec Pharmaceutical Co Ltd from 2001 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Shanghai Shyndec Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 62.8% | CN¥6.51 Billion | CN¥6.51 Billion | CN¥- | CN¥10.37 Billion | ▼ -2.5 pp |
| 2020 | 65.3% | CN¥6.41 Billion | CN¥6.41 Billion | CN¥- | CN¥9.82 Billion | ▼ -2.6 pp |
| 2019 | 67.9% | CN¥6.25 Billion | CN¥6.25 Billion | CN¥- | CN¥9.20 Billion | ▼ -6.8 pp |
| 2018 | 74.7% | CN¥6.31 Billion | CN¥6.10 Billion | CN¥211.63 Million | CN¥8.44 Billion | ▼ -14.8 pp |
| 2017 | 89.5% | CN¥6.85 Billion | CN¥6.74 Billion | CN¥102.01 Million | CN¥7.65 Billion | ▼ -16.3 pp |
| 2016 | 105.8% | CN¥7.34 Billion | CN¥7.25 Billion | CN¥95.86 Million | CN¥6.94 Billion | ▼ -336.3 pp |
| 2015 | 442.2% | CN¥7.13 Billion | CN¥7.05 Billion | CN¥76.17 Million | CN¥1.61 Billion | ▲ +310.6 pp |
| 2014 | 131.6% | CN¥1.83 Billion | CN¥1.83 Billion | CN¥- | CN¥1.39 Billion | ▲ +6.4 pp |
| 2013 | 125.2% | CN¥1.66 Billion | CN¥1.66 Billion | CN¥- | CN¥1.33 Billion | ▲ +30.3 pp |
| 2012 | 94.9% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥1.19 Billion | ▲ +40.5 pp |
| 2011 | 54.3% | CN¥514.82 Million | CN¥514.82 Million | CN¥- | CN¥947.63 Million | ▲ +3.0 pp |
| 2010 | 51.4% | CN¥430.25 Million | CN¥430.25 Million | CN¥- | CN¥837.59 Million | ▲ +7.3 pp |
| 2009 | 44.1% | CN¥314.29 Million | CN¥314.29 Million | CN¥- | CN¥713.46 Million | ▲ +5.4 pp |
| 2008 | 38.6% | CN¥243.92 Million | CN¥243.92 Million | CN¥- | CN¥631.47 Million | ▼ -3.5 pp |
| 2007 | 42.1% | CN¥250.18 Million | CN¥250.18 Million | CN¥- | CN¥594.29 Million | ▼ -2.4 pp |
| 2006 | 44.5% | CN¥227.50 Million | CN¥227.50 Million | CN¥- | CN¥511.49 Million | ▲ +2.0 pp |
| 2005 | 42.5% | CN¥203.28 Million | CN¥203.28 Million | CN¥- | CN¥478.84 Million | ▲ +20.0 pp |
| 2004 | 22.4% | CN¥99.18 Million | CN¥99.18 Million | CN¥- | CN¥441.88 Million | ▼ -27.7 pp |
| 2003 | 50.1% | CN¥71.65 Million | CN¥71.65 Million | CN¥- | CN¥143.00 Million | ▼ -5.4 pp |
| 2002 | 55.5% | CN¥63.68 Million | CN¥63.68 Million | CN¥- | CN¥114.68 Million | ▲ +1.7 pp |
| 2001 | 53.8% | CN¥51.18 Million | CN¥51.18 Million | CN¥- | CN¥95.12 Million | — |